33Indexed trials
Market Rank #47 · Evidence Tier A
Malaysia
Neuroscience Intelligence
Malaysia neuroscience intelligence: 33 indexed trials, 26 institutions, research score 27.03.
6Recruiting
26Research institutions
27.0Research score
Evidence profile
20Sponsors
9Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 27.0 · Data confidence 100.00 · Evidence 27.0
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons13trials
epilepsy5trials
schizophrenia4trials
stroke3trials
depression2trials
dementia_other2trials
alzheimers2trials
other_neurology1trials
adhd1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC9trials
Boehringer Ingelheim3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
University of Malaya2trials
Janssen Research & Development, LLC1trials
Newron Pharmaceuticals SPA1trials
Novo Nordisk A/S1trials
Bial - Portela C S.A.1trials
Region Skane1trials
Sajjad Rahman1trials